Marisabel Rodriguez Messan
Overview
Explore the profile of Marisabel Rodriguez Messan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valega-Mackenzie W, Rodriguez Messan M, Yogurtcu O, Nukala U, Sauna Z, Yang H
PLoS Comput Biol
. 2024 Mar;
20(3):e1011247.
PMID: 38427689
The advancements in next-generation sequencing have made it possible to effectively detect somatic mutations, which has led to the development of personalized neoantigen cancer vaccines that are tailored to the...
2.
Han L, Yogurtcu O, Rodriguez Messan M, Valega-Mackenzie W, Nukala U, Yang H
Math Med Biol
. 2024 Feb;
41(1):35-52.
PMID: 38408192
Drug resistance is a significant obstacle to effective cancer treatment. To gain insights into how drug resistance develops, we adopted a concept called fitness landscape and employed a phenotype-structured population...
3.
Mutanga J, Nukala U, Rodriguez Messan M, Yogurtcu O, McCormick Q, Sauna Z, et al.
AAPS J
. 2023 Feb;
25(1):24.
PMID: 36759415
The US FDA Center for Biologics Evaluation and Research (CBER) is responsible for the regulation of biologically derived products. FDA has established Advisory Committees (AC) as vehicles to seek external...
4.
Han L, Rodriguez Messan M, Yogurtcu O, Nukala U, Yang H
Math Biosci
. 2023 Jan;
356:108966.
PMID: 36642160
Cancer neoantigen vaccines have emerged as a promising approach to stimulating the immune system to fight cancer. We propose a simple model including key elements of cancer-immune interactions and conduct...
5.
Belov A, Rodriguez Messan M, Yogurtcu O, Schultz K, Maxfield K, Thompson L, et al.
Clin Pharmacol Ther
. 2022 Mar;
113(2):221-225.
PMID: 35253213
No abstract available.
6.
Rodriguez Messan M, Yogurtcu O, McGill J, Nukala U, Sauna Z, Yang H
PLoS Comput Biol
. 2021 Sep;
17(9):e1009318.
PMID: 34559809
Cancer vaccines are an important component of the cancer immunotherapy toolkit enhancing immune response to malignant cells by activating CD4+ and CD8+ T cells. Multiple successful clinical applications of cancer...
7.
Nukala U, Rodriguez Messan M, Yogurtcu O, Wang X, Yang H
AAPS J
. 2021 Apr;
23(3):52.
PMID: 33835308
Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapy that has recently become highly instrumental in the fight against life-threatening diseases. A variety of modeling and computational simulation efforts have...
8.
Rodriguez Messan M, Damaghi M, Freischel A, Miao Y, Brown J, Gillies R, et al.
Math Biosci
. 2021 Mar;
336:108575.
PMID: 33757835
This study develops a novel model of a consumer-resource system with mobility included, in order to explain a novel experiment of competition between two breast cancer cell lines grown in...
9.
Yogurtcu O, Rodriguez Messan M, Gerkin R, Belov A, Yang H, Forshee R, et al.
medRxiv
. 2021 Feb;
PMID: 33564783
Quantifying how accurate epidemiological models of COVID-19 forecast the number of future cases and deaths can help frame how to incorporate mathematical models to inform public health decisions. Here we...
10.
Rao F, Rodriguez Messan M, Marquez A, Smith N, Kang Y
J Biol Dyn
. 2020 Jul;
15(sup1):S35-S61.
PMID: 32633212
In this paper, we use an adaptive modeling framework to model and study how nutritional status (measured by the protein to carbohydrate ratio) may regulate population dynamics and foraging task...